This page is part of the HL7 Europe Common Cancer Model (v1.0.0-ballot: STU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
This page provides a list of the FHIR artifacts defined as part of this implementation guide.
These define data models that represent the domain covered by this implementation guide in more business-friendly terms than the underlying FHIR resources.
| Active Surveillance |
Logical model representing an active surveillance strategy in which the patient is monitored over time without active treatment, prior to disease progression. Derived from Cancer_Common_Logical_Model_20260521.xlsx (sheet ActiveSurveillance). |
| Cancer Patient |
Logical model describing the patient affected by cancer, acting as the central subject for diagnosis, treatments, disease evolution and follow-up. Derived from Cancer_Common_Logical_Model_20260521.xlsx (sheet CancerPatient). |
| CancerConditionAtDiagnosis |
Logical model representing the cancer condition at first diagnosis, capturing initial tumour characteristics and the diagnostic context that initiates the cancer journey. Derived from Cancer_Common_Logical_Model_20260521.xlsx (sheet CancerConditionAtDiagnosis). |
| CancerStage |
Logical model representing the cancer stage at the time of first diagnosis. The stage may be clinical or pathological: the clinical stage is derived from imaging evidence, while the pathological stage, when available, is derived from surgical evidence. Derived from Cancer_Common_Logical_Model_20260521.xlsx (sheet CancerStage). |
| ClinicalCancerProgression |
Logical model representing the longitudinal evolution of the cancer disease, documenting disease status and extent at a specific point in time. Derived from Cancer_Common_Logical_Model_20260521.xlsx (sheet ClinicalCancerProgression). |
| Imaging |
Logical model representing a diagnostic imaging procedure performed to define the diagnosis and the clinical stage. Derived from Cancer_Common_Logical_Model_20260521.xlsx (sheet Imaging). |
| LastFollowUp |
Logical model representing the assessment of the patient’s status at a specific follow-up visit, including vital status and evidence of disease. Derived from Cancer_Common_Logical_Model_20260521.xlsx (sheet LastFollowUp). |
| OverallCancerTreatmentResponse |
Logical model representing the overall assessment of the cancer’s response to one or more treatment episodes at a specific time point. Derived from Cancer_Common_Logical_Model_20260521.xlsx (sheet OverallCancerTreatmentResponse). |
| Radiotherapy |
Logical model representing a radiotherapy treatment course administered to the patient, including intent, timing, and anatomical target. Derived from Cancer_Common_Logical_Model_20260521.xlsx (sheet Radiotherapy). |
| Surgery |
Logical model representing a surgical treatment episode delivered to the patient for cancer management. Derived from Cancer_Common_Logical_Model_20260521.xlsx (sheet Surgery). |
| SystemicTreatment |
Logical model representing a systemic anti-cancer treatment episode delivered to the patient, either at diagnosis or following disease progression. Derived from Cancer_Common_Logical_Model_20260521.xlsx (sheet SystemicTreatment). |
These define constraints on FHIR resources for systems conforming to this implementation guide.
| Observation: Comorbidities |
This informative profile constrains the Observation resource to represent Comorbidities for the purpose of the ECCDM. It is provided as future implementation-oriented content in this publication and is expected to evolve in subsequent iterations of this guide. This profiles is adapted from the mCode FHIR Implementation Guide |
| Patient (CCM) |
This informative profile defines how to represent Patient in FHIR for the purpose of the ECCDM. It is provided as future implementation-oriented content in this publication and is expected to evolve in subsequent iterations of this guide. |
These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.
| Cancer Condition at Diagnosis Example |
Example cancer condition at diagnosis for a lung adenocarcinoma case. |
| Cancer Patient Example |
Example patient record for the cancer common example scenario. |
| Clinical Cancer Progression 1 Example |
Example clinical cancer progression showing complete remission on 2018-10-30. |
| Clinical Cancer Progression 2 Example |
Example clinical cancer progression showing complete remission on 2019-02-28. |
| Clinical Cancer Progression 3 Example |
Example clinical cancer progression showing complete remission on 2019-05-30. |
| Clinical Cancer Progression 4 Example |
Example clinical cancer progression documenting loco-regional recurrence on 2019-08-31. |
| Clinical Cancer Progression 5 Example |
Example clinical cancer progression documenting partial remission on 2020-01-02. |
| Clinical Cancer Progression 6 Example |
Example clinical cancer progression documenting metastatic progression on 2020-04-15. |
| Clinical Cancer Stage Example |
Example clinical TNM stage for the cancer condition at diagnosis. |
| ComorbidityObservation1-Example |
Example comorbidity observation documenting the Charlson Comorbidity Index and associated comorbid conditions. |
| Imaging Example |
Example magnetic resonance imaging record for the lower lobe of the lung. |
| Last Follow-Up 1 Example |
Example follow-up with the patient alive and no evidence of disease on 2018-10-30. |
| Last Follow-Up 2 Example |
Example follow-up with the patient alive and no evidence of disease on 2019-02-28. |
| Last Follow-Up 3 Example |
Example follow-up with the patient alive and no evidence of disease on 2019-05-30. |
| Last Follow-Up 4 Example |
Example follow-up with the patient alive and evidence of disease on 2019-08-31. |
| Last Follow-Up 5 Example |
Example follow-up with the patient alive and evidence of disease on 2020-01-02. |
| Last Follow-Up 6 Example |
Example follow-up with the patient alive and evidence of disease on 2020-04-15. |
| Last Follow-Up 7 Example |
Example final follow-up documenting death from malignant neoplasm of bronchus and lung. |
| Overall Cancer Treatment Response 1 Example |
Example overall treatment response documenting complete remission on 2018-10-30. |
| Overall Cancer Treatment Response 2 Example |
Example overall treatment response documenting partial remission on 2020-01-02. |
| Pathological Cancer Stage Example |
Example pathological TNM stage supported by the surgery example. |
| Patient1-Example |
Example patient used in Cancer Common implementation guide examples. |
| Practitioner1-Example |
Example practitioner acting as performer of clinical observations. |
| Radiotherapy Example |
Example postoperative adjuvant radiotherapy treatment for the cancer condition. |
| Surgery Example |
Example definitive surgery for the lower lobe lung cancer condition. |
| Systemic Treatment 1 Example |
Example chemotherapy treatment following the loco-regional recurrence. |
These are resources that are used within this implementation guide that do not fit into one of the other categories.
| Parameters for Terminology expansion using Snomed-CT international edition |
This parameter resource is used to specify the system version of international SNOMED CT to be used in the terminology service. |